Vernakalant is a class III antiarrhythmic agent primarily used for the rapid conversion of recent-onset atrial fibrillation and atrial flutter to sinus rhythm. This category provides essential pharmaceutical… Read more









Vernakalant is a class III antiarrhythmic agent primarily used for the rapid conversion of recent-onset atrial fibrillation and atrial flutter to sinus rhythm. This category provides essential pharmaceutical reference standards required for analytical testing and rigorous quality control protocols. Laboratories utilize these high-quality materials, including specific stereoisomeric impurities and stable isotope labelled compounds like Vernakalant-d6, to ensure accurate impurity profiling and to support comprehensive method validation. By incorporating these reference standards into analytical workflows, researchers can reliably identify and quantify related substances in drug substances and finished pharmaceutical products. These reference materials are critical for maintaining regulatory compliance and ensuring the consistent safety and efficacy of therapeutic formulations containing this antiarrhythmic agent.